MDWD MediWound Ltd.

BULLISH Impact: 4/10 Insider Cluster (2 insiders)
Horizon weeks Filed Jun 2, 2026 Processed 12d 21h ago
Insider cluster: 2 insiders, $27K total
Latest settled — T+1d
MDWD ▼ -0.22% at T+1d
LONG call ✗ call lost -0.22% · α vs SPY +0.48% · entry $13.76 → $13.73
Next anchor: T+5d due 6d ago
Last close $14.22 (close Jun 12) · +3.34% from $13.76 entry
Entry anchored
Jun 1, 03:59 PM ET
via Databento tick
T+1d
-0.22%
call -0.22% · α +0.48%
$13.73
settled 12d ago
T+5d
call — · α —
due 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two MediWound directors made open-market purchases totaling $27K over a 4-day window. While the dollar amount is small relative to the $178M market cap (0.015%), cluster buys by directors are a modestly positive signal, especially given the company's 92% analyst bullish consensus.

Key Financial Metrics

Direction
buying
Total Value
$26.8K
Insiders
2

Actionable Insight

The cluster of director purchases, while small in absolute terms, is a rare bullish insider signal for MDWD. Monitor for upcoming catalysts (earnings, NexoBrid milestones) that may have prompted the buying. The 92% analyst bullish consensus suggests the market is already optimistic, so the signal is confirmatory rather than transformative.

Key Facts

  • Director David Morton Fox purchased 1,730 shares at $14.225 on June 1, 2026, for ~$24.6K.
  • Director Samuel Rubinstein purchased 150 shares at $14.33 on May 29, 2026, for ~$2.1K.
  • Total insider buying: $26.8K, representing ~0.015% of market cap.
  • Both transactions were open-market purchases (code P), not grants or exercises.
  • No insider sales were reported in the same window.

Financial Impact

Total insider purchases of $26.8K, negligible relative to $178M market cap.

Risk Factors

  • Purchase amounts are very small relative to market cap, limiting signal strength.
  • Directors may be buying for diversification or personal reasons, not informational edge.
  • Historical calibration shows cluster buys at this score level have only 31% win rate at T+20.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
92% bullish (12 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MDWD-1780399845353
6 reports for MDWD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MDWD — sortable, filterable
Type Now
Jun 2, 2026
12d ago
Insider Cluster
BULLISH ★ 4/10
$13.76 $13.73▼ −0.22%▲ +0.48%$14.22 (+3.34%)
May 27, 2026
18d ago
Press Release
BEARISH ★ 6/10
$14.33 $14.56▼ −1.60%▼ −1.05%$14.22 (+0.77%)
May 7, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$17.27 $16.57▼ −4.05%▼ −4.88%$14.22 (−17.66%)
Mar 30, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$16.11 $16.20▲ +0.56%▼ −0.19%$14.22 (−11.73%)
Mar 5, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$17.03 $17.49▲ +2.70%▲ +1.85%$14.22 (−16.50%)
Mar 5, 2026
14w ago
Press Release
BEARISH ★ 6/10
$17.45 $17.03▲ +2.41%▲ +1.09%$14.22 (+18.51%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 4h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access